March 14, 2014:  BioKier, Inc. signs exclusive global license with UCL Business PLC for colonic delivery of gut hormone secretagogues for treatment of metabolic diseases including diabetes. BioKier, Inc. has entered into an exclusive license agreement with UCL Business PLC (UCLB) for the proprietary colon delivery technology (Phloral^TM) developed by researchers at the UCL School of Pharmacy.

 

Press Release